# FS Bancorp, Inc.: financial statements, quarterly

FSBW · Nasdaq · CIK 1530249 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsbw.md) · [Financials](/companies/fsbw/financials.md) · [Filings](/companies/fsbw/filings.md) · [Insiders](/companies/fsbw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsbw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.2](/filings/0001437749-23-030868.md) | [1.2 d](/filings/0001437749-24-008140.md) | [1.1](/filings/0001437749-24-016017.md) | [1.2](/filings/0001437749-24-025823.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [3.4](/filings/0001437749-24-034233.md) | [3.3 d](/filings/0001437749-26-008243.md) | [3.0](/filings/0001437749-25-015847.md) | [3.5](/filings/0001437749-25-025677.md) | [3.8](/filings/0001437749-25-034119.md) | [3.2 d](/filings/0001437749-26-008243.md) | [3.4](/filings/0001437749-26-015942.md) | [3.8](/filings/0001437749-26-026740.md) | [4.0](/filings/0001437749-25-034119.md) | [3.7 d](/filings/0001437749-26-008243.md) | [3.4](/filings/0001437749-26-015942.md) | [2.7](/filings/0001437749-26-026740.md) |
| Interest expense | $m | [12.6](/filings/0001437749-23-030868.md) | [14.0 d](/filings/0001437749-24-008140.md) | [14.5](/filings/0001437749-24-016017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.5](/filings/0001437749-24-034233.md) | [2.3 d](/filings/0001437749-26-008243.md) | [2.1](/filings/0001437749-25-015847.md) | [2.4](/filings/0001437749-25-025677.md) | [(0.4)](/filings/0001437749-25-034119.md) | [2.5 d](/filings/0001437749-26-008243.md) | [1.4](/filings/0001437749-26-015942.md) | [2.0](/filings/0001437749-26-026740.md) | [2.4](/filings/0001437749-25-034119.md) | [1.9 d](/filings/0001437749-26-008243.md) | [2.1](/filings/0001437749-26-015942.md) | [2.1](/filings/0001437749-26-026740.md) |
| Net income | $m | [9.0](/filings/0001437749-24-034233.md) | [9.8 d](/filings/0001437749-26-008243.md) | [8.4](/filings/0001437749-25-015847.md) | [9.0](/filings/0001437749-25-025677.md) | [10.3](/filings/0001437749-25-034119.md) | [7.4 d](/filings/0001437749-26-008243.md) | [8.0](/filings/0001437749-26-015942.md) | [7.7](/filings/0001437749-26-026740.md) | [9.2](/filings/0001437749-25-034119.md) | [8.4 d](/filings/0001437749-26-008243.md) | [7.8](/filings/0001437749-26-015942.md) | [7.9](/filings/0001437749-26-026740.md) |
| Diluted EPS | $ per share | [1.13](/filings/0001437749-24-034233.md) | not reported | [1.06](/filings/0001437749-25-015847.md) | [1.13](/filings/0001437749-25-025677.md) | [1.29](/filings/0001437749-25-034119.md) | not reported | [1.01](/filings/0001437749-26-015942.md) | [0.99](/filings/0001437749-26-026740.md) | [1.18](/filings/0001437749-25-034119.md) | not reported | [1.02](/filings/0001437749-26-015942.md) | [1.04](/filings/0001437749-26-026740.md) |
| Basic EPS | $ per share | [1.15](/filings/0001437749-24-034233.md) | not reported | [1.07](/filings/0001437749-25-015847.md) | [1.15](/filings/0001437749-25-025677.md) | [1.32](/filings/0001437749-25-034119.md) | not reported | [1.02](/filings/0001437749-26-015942.md) | [1.00](/filings/0001437749-26-026740.md) | [1.20](/filings/0001437749-25-034119.md) | not reported | [1.04](/filings/0001437749-26-015942.md) | [1.06](/filings/0001437749-26-026740.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [80.7](/filings/0001437749-23-030868.md) | [65.7](/filings/0001437749-25-008049.md) | [45.4](/filings/0001437749-24-016017.md) | [33.0](/filings/0001437749-24-025823.md) | [40.3](/filings/0001437749-24-034233.md) | [31.6](/filings/0001437749-26-008243.md) | [62.7](/filings/0001437749-25-015847.md) | [33.2](/filings/0001437749-25-025677.md) | [61.3](/filings/0001437749-25-034119.md) | [28.2](/filings/0001437749-26-026740.md) | [38.7](/filings/0001437749-26-015942.md) | [29.7](/filings/0001437749-26-026740.md) |
| Total assets | $m | [2,920](/filings/0001437749-23-030868.md) | [2,973](/filings/0001437749-25-008049.md) | [2,970](/filings/0001437749-24-016017.md) | [2,941](/filings/0001437749-24-025823.md) | [2,970](/filings/0001437749-24-034233.md) | [3,029](/filings/0001437749-26-008243.md) | [3,066](/filings/0001437749-25-015847.md) | [3,176](/filings/0001437749-25-025677.md) | [3,209](/filings/0001437749-25-034119.md) | [3,197](/filings/0001437749-26-026740.md) | [3,204](/filings/0001437749-26-015942.md) | [3,179](/filings/0001437749-26-026740.md) |
| Total liabilities | $m | [2,669](/filings/0001437749-23-030868.md) | [2,708](/filings/0001437749-25-008049.md) | [2,692](/filings/0001437749-24-016017.md) | [2,657](/filings/0001437749-24-025823.md) | [2,681](/filings/0001437749-24-034233.md) | [2,733](/filings/0001437749-26-008243.md) | [2,767](/filings/0001437749-25-015847.md) | [2,879](/filings/0001437749-25-025677.md) | [2,908](/filings/0001437749-25-034119.md) | [2,889](/filings/0001437749-26-026740.md) | [2,890](/filings/0001437749-26-015942.md) | [2,860](/filings/0001437749-26-026740.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [122](/filings/0001437749-23-030868.md) | [93.7](/filings/0001437749-25-008049.md) | [130](/filings/0001437749-24-016017.md) | [182](/filings/0001437749-24-025823.md) | [164](/filings/0001437749-24-034233.md) | [308](/filings/0001437749-26-008243.md) | [68.8](/filings/0001437749-25-015847.md) | [234](/filings/0001437749-25-025677.md) | [129](/filings/0001437749-25-034119.md) | [129](/filings/0001437749-26-026740.md) | [167](/filings/0001437749-26-015942.md) | [325](/filings/0001437749-26-026740.md) |
| Shareholders' equity | $m | [251](/filings/0001437749-24-034233.md) | [264](/filings/0001437749-26-008243.md) | [278](/filings/0001437749-25-025677.md) | [284](/filings/0001437749-25-034119.md) | [289](/filings/0001437749-25-034119.md) | [296](/filings/0001437749-26-026740.md) | [299](/filings/0001437749-26-026740.md) | [297](/filings/0001437749-26-026740.md) | [301](/filings/0001437749-25-034119.md) | [308](/filings/0001437749-26-026740.md) | [314](/filings/0001437749-26-026740.md) | [319](/filings/0001437749-26-026740.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.9 d](/filings/0001437749-24-034233.md) | [12.6 d](/filings/0001437749-26-008243.md) | [0.3](/filings/0001437749-25-015847.md) | [9.9 d](/filings/0001437749-25-025677.md) | [(0.9) d](/filings/0001437749-25-034119.md) | [41.5 d](/filings/0001437749-26-008243.md) | [8.2](/filings/0001437749-26-015942.md) | [7.1 d](/filings/0001437749-26-026740.md) | [44.6 d](/filings/0001437749-25-034119.md) | [12.4 d](/filings/0001437749-26-008243.md) | [8.7](/filings/0001437749-26-015942.md) | [52.0 d](/filings/0001437749-26-026740.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001437749-24-034233.md) | [0.3 d](/filings/0001437749-26-008243.md) | [0.4](/filings/0001437749-25-015847.md) | [0.3 d](/filings/0001437749-25-025677.md) | [0.6 d](/filings/0001437749-25-034119.md) | [0.4 d](/filings/0001437749-26-008243.md) | [0.4](/filings/0001437749-26-015942.md) | [1.3 d](/filings/0001437749-26-026740.md) | [3.0 d](/filings/0001437749-25-034119.md) | [15.7 d](/filings/0001437749-26-008243.md) | [0.3](/filings/0001437749-26-015942.md) | [0.6 d](/filings/0001437749-26-026740.md) |
| Dividends paid | $m | [1.9 d](/filings/0001437749-24-034233.md) | [2.0 d](/filings/0001437749-26-008243.md) | [2.0](/filings/0001437749-25-015847.md) | [2.0 d](/filings/0001437749-25-025677.md) | [2.1 d](/filings/0001437749-25-034119.md) | [2.1 d](/filings/0001437749-26-008243.md) | [2.2](/filings/0001437749-26-015942.md) | [2.2 d](/filings/0001437749-26-026740.md) | [3.8 d](/filings/0001437749-25-034119.md) | [2.1 d](/filings/0001437749-26-008243.md) | [2.2](/filings/0001437749-26-015942.md) | [2.2 d](/filings/0001437749-26-026740.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-034233.md) | [0.2 d](/filings/0001437749-26-008243.md) | [0.0](/filings/0001437749-25-015847.md) | [2.4 d](/filings/0001437749-25-025677.md) | [0.1 d](/filings/0001437749-25-034119.md) | [0.0 d](/filings/0001437749-26-008243.md) | [3.8](/filings/0001437749-26-015942.md) | [5.2 d](/filings/0001437749-26-026740.md) | [4.9 d](/filings/0001437749-25-034119.md) | [1.5 d](/filings/0001437749-26-008243.md) | [0.6](/filings/0001437749-26-015942.md) | [3.6 d](/filings/0001437749-26-026740.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,708](/filings/0001437749-23-030868.md) | [7,778](/filings/0001437749-24-016017.md) | [7,746](/filings/0001437749-24-025823.md) | [7,780](/filings/0001437749-24-034233.md) | [7,824](/filings/0001437749-25-015847.md) | [7,796](/filings/0001437749-25-025677.md) | [7,854](/filings/0001437749-25-034119.md) | [7,806](/filings/0001437749-26-015942.md) | [7,698](/filings/0001437749-26-026740.md) | [7,623](/filings/0001437749-25-034119.md) | [7,531](/filings/0001437749-26-015942.md) | [7,483](/filings/0001437749-26-026740.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,431,972 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001437749-26-026740.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.